Impact of COVID-19 on patterns of drug use and drug-related harms in Europe
Monografía Alcohol 2021. Consumo y consecuencias
Plan Estratégico para el Abordaje de la Hepatitis C en el Sistema Nacional de Salud
Preventing harmful alcohol use
COVID-19 and smoking: A systematic review of the evidence
EU drug markets. Impact of Covid-19
Expanding access to prevention, care and treatment for hepatitis C virus infection among people who inject drugs
Familias de consumidores de drogas: respuestas sanitarias y sociales: una guía europea
Impact of COVID-19 on drug markets, use, harms and drug services in the community and prisons. Results from an EMCDDA trendspotter study
Covid-19, consumo de sustancias psicoactivas y adicciones en España
Sustancias sicotrópicas 2021
Sustancias sicotrópicas 2022
EMCDDA special report COVID-19 and drugs. Drug supply via darknet markets
Domestic abuse and change resistant drinkers: preventing and reducing the harm
El impacto de la COVID-19 y sus consecuencias en el ámbito de las adicciones en Euskadi = COVID-19aren inpaktua eta ondorioak adikzioen eremuan, Euskadin
Covid-19 and people who use drugs. Essential interventions to save lives and protect people
Impact of COVID-19 on drug services and help-seeking in Europe
World health statistics 2018. Monitoring health for the SDGs (Sustainable Development Goals)
Consumo de alcohol y violencia de género. Perspectiva de los y las profesionales del ámbito de las drogodependencias, jurídico y social
Interleave Research Report. Women who use drugs facing gender-based violence in Europe
Relation between family history of substance use, co-occurring mental health disorders, history of emotional, physical or sexual abuse and adversities, and treatment responses and outcome. Implications for public health and drug policies
Las cifras del cáncer en España 2023
Current smoking and COVID-19 risk: results from a population symptom app in over 2.4 million people
Mujeres, violencias y exclusión. Una guía de buenas prácticas